EDRS
ICPT

Edmond de Rothschild (Suisse)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-550
Closed -$133K – 470
2015
Q2 		$133K Buy
+550
New +$146K 0.04% 195

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s ICPT Position: Q3 2015 in Review

Edmond de Rothschild (Suisse) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2015, closing a stake of 550 shares — an estimated $133K sold.

Edmond de Rothschild (Suisse) first reported a position in ICPT in Q2 2015 and held it in 1 quarter. The position peaked at $133K in Q2 2015. 173 funds tracked by Wall St. Rank hold ICPT as of Q3 2015.

  • Edmond de Rothschild (Suisse) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Edmond de Rothschild (Suisse) sold 550 Intercept Pharmaceuticals, Inc. shares in Q3 2015, an estimated $133K.
  • Edmond de Rothschild (Suisse) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • Edmond de Rothschild (Suisse)'s Intercept Pharmaceuticals, Inc. position peaked at $133K in Q2 2015.
  • 173 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2015.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2015, filed 16 Nov 2015.